Prostate cancer antigen 3 moderately improves diagnostic accuracy in Chinese patients undergoing first prostate biopsy

Prostate cancer antigen 3 (PCA3) is a biomarker for diagnosing prostate cancer (PCa) identified in the Caucasian population. We evaluated the effectiveness of urinary PCA3 in predicting the biopsy result in 500 men undergoing initial prostate biopsy. The predictive power of the PCA3 score was evalua...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Fu-Bo, Chen, Rui, Ren, Shan-Cheng, Shi, Xiao-Lei, Zhu, Ya-Sheng, Zhang, Wei, Jing, Tai-Le, Zhang, Chao, Gao, Xu, Hou, Jian-Guo, Xu, Chuan-Liang, Sun, Ying-Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5312226/
https://www.ncbi.nlm.nih.gov/pubmed/26780868
http://dx.doi.org/10.4103/1008-682X.167715

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5312226/
https://www.ncbi.nlm.nih.gov/pubmed/26780868
http://dx.doi.org/10.4103/1008-682X.167715

Ejemplares similares